Sarah Cannon Research Institute
Justin Aguilar is a finance professional with extensive experience in financial planning and analysis. Currently serving as the Manager of Financial Planning and Analysis at Sarah Cannon Research Institute since April 2021, Justin previously held the role of Senior Financial Analyst. Prior to that position, Justin worked as a Financial Analyst in FP&A at IAA from August 2019 to April 2021 and as a Client Financial Analyst at Havas Chicago from May 2018 to August 2019. Justin holds a Bachelor's degree in Finance from the University of Arkansas, which was completed between 2016 and 2018.
This person is not in any offices
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.